Macquarie Group’s Encompass Health EHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-395,008
Closed -$50.2M 1047
2025
Q3
$50.2M Buy
395,008
+11,899
+3% +$1.42M 0.06% 421
2025
Q2
$47M Sell
383,109
-74,168
-16% -$8.47M 0.06% 430
2025
Q1
$46.3M Sell
457,277
-80,158
-15% -$7.83M 0.06% 423
2024
Q4
$49.6M Sell
537,435
-3,853
-0.7% -$378K 0.06% 421
2024
Q3
$52.3M Sell
541,288
-34,735
-6% -$3.12M 0.06% 437
2024
Q2
$49.4M Buy
576,023
+11,870
+2% +$996K 0.06% 419
2024
Q1
$46.6M Buy
564,153
+337,870
+149% +$24.7M 0.05% 448
2023
Q4
$15.1M Sell
226,283
-11,605
-5% -$752K 0.02% 737
2023
Q3
$16M Buy
237,888
+87,182
+58% +$6M 0.02% 681
2023
Q2
$10.2M Sell
150,706
-735,701
-83% -$46.1M 0.01% 784
2023
Q1
$48M Buy
886,407
+83,753
+10% +$4.88M 0.06% 435
2022
Q4
$48M Sell
802,654
-148,328
-16% -$8.07M 0.06% 451
2022
Q3
$43.1M Sell
950,982
-185,969
-16% -$9.3M 0.05% 471
2022
Q2
$50.7M Sell
1,136,951
-213
-0% -$10.9K 0.06% 444
2022
Q1
$64.3K Sell
1,137,164
-285,605
-20% -$14.9M 0.05% 436
2021
Q4
$73.9M Sell
1,422,769
-63,236
-4% -$3.26M 0.06% 395
2021
Q3
$88.7M Buy
1,486,005
+189,587
+15% +$11.9M 0.08% 338
2021
Q2
$80.5M Buy
1,296,418
+1,172,083
+943% +$78.1M 0.07% 373
2021
Q1
$8.1M Sell
124,335
-4,200
-3% -$274K 0.01% 777
2020
Q4
$8.46M Sell
128,535
-9,386
-7% -$552K 0.01% 754
2020
Q3
$7.13M Buy
137,921
+4,449
+3% +$228K 0.01% 734
2020
Q2
$6.58M Buy
133,472
+14,878
+13% +$803K 0.01% 733
2020
Q1
$6.04M Sell
118,594
-4,528
-4% -$261K 0.01% 673
2019
Q4
$6.79M Buy
123,122
+20,715
+20% +$1.12M 0.01% 728
2019
Q3
$5.16M Sell
102,407
-22,380
-18% -$1.12M 0.01% 756
2019
Q2
$6.29M Sell
124,787
-5,688
-4% -$276K 0.01% 710
2019
Q1
$6.06M Sell
130,475
-8,911
-6% -$451K 0.01% 724
2018
Q4
$6.84M Sell
139,386
-232,108
-62% -$13.2M 0.01% 684
2018
Q3
$23M Sell
371,494
-482,563
-57% -$29.3M 0.04% 441
2018
Q2
$46M Sell
854,057
-335,438
-28% -$16.8M 0.08% 264
2018
Q1
$54.1M Buy
1,189,495
+1,188,458
+114,605% +$50.9M 0.1% 203
2017
Q4
$41K Sell
1,037
-1,162,618
-100% -$44.2M ﹤0.01% 2022
2017
Q3
$42.9M Buy
1,163,655
+132,432
+13% +$4.72M 0.08% 245
2017
Q2
$39.7M Buy
1,031,223
+371,542
+56% +$13.6M 0.07% 252
2017
Q1
$22.5M Buy
659,681
+22,212
+3% +$729K 0.04% 427
2016
Q4
$20.9M Buy
637,469
+39,885
+7% +$1.29M 0.04% 423
2016
Q3
$19.3M Sell
597,584
-31,987
-5% -$1.04M 0.04% 427
2016
Q2
$19.4M Buy
629,571
+499,913
+386% +$15.6M 0.02% 578
2016
Q1
$3.88M Buy
129,658
+97,645
+305% +$2.7M 0.01% 775
2015
Q4
$887K Buy
32,013
+3,850
+14% +$110K ﹤0.01% 1099
2015
Q3
$860K Sell
28,163
-10,804
-28% -$376K ﹤0.01% 1158
2015
Q2
$1.43M Hold
38,967
﹤0.01% 1105
2015
Q1
$1.38M Buy
38,967
+7,542
+24% +$258K ﹤0.01% 1089
2014
Q4
$962K Hold
31,425
﹤0.01% 1170
2014
Q3
$923K Hold
31,425
﹤0.01% 1176
2014
Q2
$897K Hold
31,425
﹤0.01% 1215
2014
Q1
$898K Hold
31,425
﹤0.01% 1182
2013
Q4
$833K Sell
31,425
-15,084
-32% -$420K ﹤0.01% 1187
2013
Q3
$1.28M Buy
46,509
+20,112
+76% +$516K ﹤0.01% 1100
2013
Q2
$605K Buy
+26,397
New +$597K ﹤0.01% 1246

Other funds holding EHC

Macquarie Group's EHC Position: Q4 2025 in Review

Macquarie Group sold out of Encompass Health (EHC) in Q4 2025, closing a stake of 395,008 shares — an estimated $50.2M sold.

Macquarie Group first reported a position in EHC in Q2 2013 and held it in 50 quarters. The position peaked at $88.7M in Q3 2021. 593 funds tracked by Wall St. Rank hold EHC as of Q4 2025.

  • Macquarie Group reported no remaining Encompass Health position as of Q4 2025 after selling out during the quarter.
  • Macquarie Group sold 395,008 Encompass Health shares in Q4 2025, an estimated $50.2M.
  • Macquarie Group first reported a position in Encompass Health in Q2 2013 and held it in 50 quarters.
  • Macquarie Group's Encompass Health position peaked at $88.7M in Q3 2021.
  • 593 funds tracked by Wall St. Rank held Encompass Health as of Q4 2025.

Based on Macquarie Group's 13F filing for Q4 2025, filed 13 Feb 2026.